CWM
RLAY icon

CIBC World Markets’s Relay Therapeutics RLAY Stock Holding History

CIBC World Markets’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$56.5K Sell
16,316
-11,601
-42% -$34.5K ﹤0.01% 1461
2025
Q1 		$73.1K Buy
27,917
+16,529
+145% +$64.8K ﹤0.01% 1660
2024
Q4 		$46.9K Buy
+11,388
New +$62K ﹤0.01% 1260

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIBC World Markets's RLAY Position: Q2 2025 in Review

CIBC World Markets reduced its Relay Therapeutics (RLAY) stake by 42% in Q2 2025, selling an estimated $34.5K and leaving 16,316 shares worth $56.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1461.

CIBC World Markets first reported a position in RLAY in Q4 2024 and has held it in 3 quarters since. The position peaked at $73.1K in Q1 2025. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • CIBC World Markets held 16,316 shares of Relay Therapeutics worth $56.5K as of Q2 2025.
  • CIBC World Markets sold 11,601 Relay Therapeutics shares in Q2 2025, an estimated $34.5K.
  • Relay Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1461 holding.
  • CIBC World Markets first reported a position in Relay Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Relay Therapeutics position peaked at $73.1K in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.